Bioventus Inc.

BVS

Bioventus Inc.

BVS

Insider Sentiment (TTM):

Last Purchase:2024-08-19Last Sale:2026-03-11Shares Purchased (TTM):0Shares Sold (TTM):39,701

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:50,178,526Shares Outstanding:67,296,336Institutional Ownership Pct.:74.56%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Surgical & Medical Instruments & Apparatus

SYK BSX MMM BDX IDXG MDLN

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	36	51	42	33	23	42	43	32	25	37	27	29
Accounts Receivable Net Current	121	128	130	132	118	127	122	137	126	123	113	120
Inventory Net	83	82	96	96	94	92	90	88	97	91	98	96
Prepaid Expense And Other Assets Current	10	11	12	13	14	14	17	24	18	17	12	15
Assets Of Disposal Group Including Discontinued Op…	-	-	-	-	-	-	-	-	-	0	0	0
Assets Held For Sale Not Part Of Disposal Group Cu…	-	-	-	-	-	-	27	28	-	-	-	-
Assets Current	250	273	281	275	249	276	299	309	266	268	249	261
Property Plant And Equipment And Finance Lease Rig…	21	22	23	25	26	27	29	32	35	37	40	42
Goodwill	7	7	7	7	7	7	7	7	7	7	7	7
Intangible Assets Net Excluding Goodwill	360	368	377	387	396	405	415	425	471	482	493	505
Operating Lease Right Of Use Asset	5	5	6	6	7	7	10	10	12	13	14	15
Deferred Income Tax Assets Net	6	-	5	5	5	-	7	7	-	-	-	-
Long Term Investments	2	2	2	2	2	2	2	2	3	3	7	7
Disposal Group Including Discontinued Operation As…	-	-	-	-	-	-	-	-	-	0	0	0
Assets	651	684	702	707	691	728	769	792	794	811	811	837
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	24	11	27	24	19	24	17	24	19	23	18	41
Accrued Liabilities Current	101	130	119	114	103	136	129	140	114	120	119	122
Long Term Debt Current	19	15	11	43	37	27	39	39	36	28	20	11
Business Combination Contingent Consideration Liab…	-	0	0	0	11	20	19	19	-	0	-	-
Other Liabilities Current	4	4	4	4	4	4	4	4	5	5	5	5
Liabilities Current	148	160	162	186	175	210	211	231	173	175	161	179
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	-	-	-	0	0	0
Long Term Debt Noncurrent	253	279	311	298	309	308	345	345	355	367	375	375
Deferred Income Tax Liabilities Net	1	0	1	1	1	1	0	0	1	1	0	0
Other Liabilities Noncurrent	14	15	20	21	22	23	26	27	28	28	31	32
Business Combination Contingent Consideration Liab…	-	-	-	-	-	0	0	0	18	18	18	18
Liabilities	416	455	494	505	506	542	583	603	577	590	585	604
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	-	-	-	0	0	0
Stockholders Equity Inclu…
Additional Paid In Capital	523	521	518	515	510	508	503	501	497	494	492	491
Retained Earnings Accumulated Deficit	-332	-335	-350	-353	-360	-358	-355	-350	-326	-322	-315	-308
Accumulated Other Comprehensive Income Loss Net Of…	-2	-2	-2	-1	-2	-3	0	-0	0	1	0	1
Stockholders Equity	189	184	166	201	185	186	187	151	217	221	226	183
Minority Interest	45	44	41	40	37	38	38	38	46	48	49	50
Liabilities And Stockholders Equity	651	684	702	707	691	728	769	792	794	811	811	837
Common Class A	68	0	0	1	66	0	0	1	64	0	0	0
Common Class B	16	0	0	0	16	0	0	0	16	16	0	0
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-22.07%	-10.44%	8.06%	-	-	-	-	-	-	-	-	-
2025	4.52%	9.19%	5.97%	1.51%	-8.64%	-4.80%	0.53%	-1.19%	6.23%	-1.76%	10.88%	1.98%
2024	30.66%	12.30%	45.90%	24.23%	43.88%	63.29%	7.06%	-7.49%	-12.63%	-22.87%	-32.04%	-40.00%
2023	125.83%	142.50%	200.00%	-9.54%	-14.95%	-15.21%	15.51%	45.98%	25.21%	-9.64%	-29.11%	19.46%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.69	1.70	1.74	1.48	1.43	1.31	1.41	1.33	1.53	1.53	1.55	1.46
Quick Ratio	1.06	1.12	1.07	0.89	0.81	0.80	0.91	0.85	0.87	0.91	0.87	0.83
Working Capital	101.72M	112.46M	119.15M	89.52M	74.62M	65.21M	87.20M	77.42M	92.58M	92.50M	88.61M	81.53M
Leverage & Debt
Debt to Equity	2.20	1.99	2.98	2.51	2.73	2.92	3.12	4.00	2.65	2.67	2.58	3.29
Interest Coverage TTM	2.47	2.04	1.40	1.03	-0.42	-0.39	-0.54	-0.56	0.37	-2.01	-2.61	-7.28
Debt Ratio	0.64	0.67	0.70	0.72	0.73	0.75	0.76	0.76	0.73	0.73	0.72	0.72
Efficiency & Turnover
Asset Turnover TTM	0.86	0.80	0.77	0.75	0.76	0.75	0.70	0.66	0.62	0.47	0.46	0.50
Days Sales Outstanding TTM	75.56	82.14	81.67	87.24	78.32	79.64	77.21	87.34	85.21	92.29	88.97	93.87
Receivables Turnover TTM	4.83	4.44	4.47	4.18	4.66	4.58	4.73	4.18	4.28	3.96	4.10	3.89
Per Share Metrics
Diluted EPS TTM	0.43	0.33	-0.10	-0.22	-0.69	-0.73	-3.22	-3.31	-0.35	-2.49	-0.56	-2.78
Free Cash Flow Per Share TTM	1.50	1.08	0.80	0.51	0.36	0.59	0.45	0.13	0.04	0.13	-0.00	0.13
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	68.69%	68.33%	67.76%	67.60%	67.45%	67.72%	67.00%	66.53%	65.55%	64.06%	62.87%	63.01%
Operating Profit Margin TTM	9.98%	9.50%	7.48%	6.13%	-2.69%	-2.65%	-3.92%	-4.28%	2.92%	-15.95%	-19.60%	-44.61%
Net Profit Margin TTM	5.21%	4.00%	-1.26%	-2.73%	-8.01%	-8.21%	-37.82%	-39.49%	-4.20%	-30.49%	-7.03%	-34.03%
Growth Metrics
Net Revenue Growth (1Y)	1.52%	-0.91%	1.58%	5.08%	8.60%	11.89%	10.40%	5.14%	1.72%	0.04%	-2.70%	2.76%
Net Income Growth (1Y)	-165.96%	-148.32%	-96.63%	-92.74%	107.01%	-69.88%	493.51%	22.03%	-93.56%	-26.79%	-72.97%	-1,359.05%
EPS Growth (1Y)	-164.70%	-146.81%	-96.71%	-93.00%	98.77%	-70.77%	471.37%	19.16%	-93.69%	-28.26%	-73.46%	-1,337.39%
Valuation Metrics
P/E TTM	20.48	21.81	-63.25	-28.59	-13.28	-14.41	-3.72	-1.74	-15.00	-2.11	-5.86	-1.04
P/B TTM	3.25	2.17	2.70	2.19	3.26	3.65	4.17	2.44	1.52	1.49	0.92	0.99
P/S TTM	1.07	0.87	0.79	0.78	1.06	1.18	1.40	0.69	0.63	0.64	0.41	0.35
Market Cap	614.42M	495.67M	447.73M	440.23M	603.98M	677.75M	779.84M	368.33M	329.58M	330.15M	207.32M	180.77M
Enterprise Value	850.65M	738.39M	728.15M	748.56M	927.11M	971.79M	1.12B	719.61M	695.64M	688.03M	575.11M	537.27M
Calculated Values
Free Cash Flow TTM	100.63M	72.11M	53.47M	34.10M	23.93M	37.79M	29.05M	8.44M	2.76M	7.98M	-182.00K	7.82M
Net Debt	236.23M	242.71M	280.42M	308.33M	323.13M	294.05M	340.51M	351.29M	366.07M	357.88M	367.79M	356.50M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-11Sale

Owner: Mcmurry-Heath, Michelle

Title: -

Shares: 12,000

Price/Share: $8.79

Value: $105,480.00

Shares Owned: 44,997

Relationship: Director

Ownership: Direct

2025-12-04Sale

Owner: Nohra, Guy P

Title: -

Shares: 10,000

Price/Share: $7.57

Value: $75,700.00

Shares Owned: 116,610

Relationship: Director

Ownership: Direct

2025-11-07Sale

Owner: Mcmurry-Heath, Michelle

Title: -

Shares: 17,701

Price/Share: $7.42

Value: $131,341.42

Shares Owned: 56,997

Relationship: Director

Ownership: Direct

2025-04-11Sale

Owner: D'Adamio, Anthony

Title: SVP & General Counsel

Shares: 2,958

Price/Share: $7.57

Value: $22,392.06

Shares Owned: 131,416

Relationship: Officer

Ownership: Direct

2025-04-11Sale

Owner: Singleton, Mark Leonard

Title: SVP & CFO

Shares: 3,875

Price/Share: $7.57

Value: $29,333.75

Shares Owned: 141,088

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-11	Mcmurry-Heath, Michelle	Director	-	Direct	Sale	12,000	8.79	$105,480.00	44,997	4
2025-12-04	Nohra, Guy P	Director	-	Direct	Sale	10,000	7.57	$75,700.00	116,610	4
2025-11-07	Mcmurry-Heath, Michelle	Director	-	Direct	Sale	17,701	7.42	$131,341.42	56,997	4
2025-04-11	D'Adamio, Anthony	Officer	SVP & General Counsel	Direct	Sale	2,958	7.57	$22,392.06	131,416	4
2025-04-11	Singleton, Mark Leonard	Officer	SVP & CFO	Direct	Sale	3,875	7.57	$29,333.75	141,088	4
2025-04-11	Church, Katrina J	Officer	SVP & Chief Compliance Officer	Direct	Sale	1,283	7.57	$9,712.31	55,557	4
2025-03-24	Singleton, Mark Leonard	Officer	SVP & CFO	Direct	Sale	5,479	9.79	$53,639.41	131,963	4
2025-03-17	Church, Katrina J	Officer	SVP & Chief Compliance Officer	Direct	Sale	1,018	9.75	$9,925.50	52,540	4
2025-03-17	D'Adamio, Anthony	Officer	SVP & General Counsel	Direct	Sale	2,615	9.75	$25,496.25	124,449	4
2025-02-18	Church, Katrina J	Officer	SVP & Chief Compliance Officer	Direct	Sale	1,537	10.19	$15,662.03	50,102	4
2025-02-18	Singleton, Mark Leonard	Officer	SVP & CFO	Direct	Sale	6,498	10.19	$66,214.62	118,817	4
2025-02-18	D'Adamio, Anthony	Officer	SVP & General Counsel	Direct	Sale	4,380	10.19	$44,632.20	118,178	4
2025-01-13	Claypoole, Robert E	Director,Officer	President and CEO	Direct	Sale	28,786	9.10	$261,952.60	64,964	4
2024-12-23	Singleton, Mark Leonard	Officer	SVP & CFO	Direct	Sale	10,733	10.53	$113,018.49	105,162	4
2024-12-23	Church, Katrina J	Officer	SVP & Chief Compliance Officer	Direct	Sale	2,535	10.53	$26,693.55	47,264	4
2024-12-23	D'Adamio, Anthony	Officer	SVP & General Counsel	Direct	Sale	5,848	10.53	$61,579.44	109,578	4
2024-08-19	Bartholdson, John A.	Director,TenPercentOwner	-	Indirect	Purchase	25,500	8.55	$218,025.00	6,939,357	4
2024-06-21	Church, Katrina J	Officer	SVP & Chief Compliance Officer	Direct	Sale	2,559	5.57	$14,253.63	41,199	4
2024-06-21	Singleton, Mark Leonard	Officer	SVP & CFO	Direct	Sale	9,219	5.57	$51,349.83	84,895	4
2024-06-21	D'Adamio, Anthony	Officer	SVP & General Counsel	Direct	Sale	5,904	5.57	$32,885.28	95,576	4
2024-06-17	Church, Katrina J	Officer	SVP & Chief Compliance Officer	Direct	Sale	8,759	5.84	$51,152.56	35,158	4
2024-06-17	Singleton, Mark Leonard	Officer	SVP & CFO	Direct	Sale	13,753	5.84	$80,317.52	63,114	4
2024-06-17	D'Adamio, Anthony	Officer	SVP & General Counsel	Direct	Sale	11,308	5.84	$66,038.72	81,630	4
2024-04-11	Church, Katrina J	Officer	SVP & Chief Compliance Officer	Direct	Sale	1,325	4.75	$6,293.75	17,042	4
2024-04-11	Singleton, Mark Leonard	Officer	SVP & CFO	Direct	Sale	4,000	4.75	$19,000.00	34,665	4
2024-04-11	D'Adamio, Anthony	Officer	SVP & General Counsel	Direct	Sale	3,054	4.75	$14,506.50	58,242	4
2024-03-22	Singleton, Mark Leonard	Officer	SVP & CFO	Direct	Sale	5,541	5.39	$29,865.99	25,665	4
2024-03-15	Church, Katrina J	Officer	SVP & Chief Compliance Officer	Direct	Sale	1,217	5.46	$6,644.82	14,067	4
2024-03-15	D'Adamio, Anthony	Officer	SVP & General Counsel	Direct	Sale	3,125	5.46	$17,062.50	51,371	4
2023-08-18	Bihl, Anthony P Iii	Director,Officer	Interim CEO	Direct	Purchase	13,290	4.14	$55,020.60	138,290	4
2023-08-14	Bartholdson, John A.	Director,TenPercentOwner	-	Indirect	Purchase	14,985	4.79	$71,778.15	6,833,857	4
2023-08-14	Juniper, Investment Compa…	TenPercentOwner	-	Indirect	Purchase	14,985	4.79	$71,778.15	6,833,857	4
2023-08-10	Bartholdson, John A.	Director,TenPercentOwner	-	Indirect	Purchase	111,848	4.47	$499,960.56	6,768,835	4
2023-07-03	Church, Katrina J	Officer	SVP & Chief Compliance Officer	Direct	Sale	394	2.83	$1,115.02	11,828	4
2023-06-15	Bartholdson, John A.	Director,TenPercentOwner	-	Indirect	Purchase	110,180	3.61	$397,749.80	6,656,987	4
2023-06-13	Bartholdson, John A.	Director,TenPercentOwner	-	Indirect	Purchase	60,324	3.05	$183,988.20	6,364,861	4
2023-05-25	Hawkins, William A	Director	-	Direct	Purchase	44,000	2.66	$117,040.00	184,310	4
2023-05-23	Bihl, Anthony P Iii	Director,Officer	Interim CEO	Direct	Purchase	125,000	2.33	$291,250.00	125,000	4
2023-05-22	Bartholdson, John A.	Director	-	Indirect	Purchase	178,998	2.08	$372,315.84	5,909,136	4
2023-04-03	Church, Katrina J	Officer	SVP & Chief Compliance Officer	Direct	Sale	117	1.07	$125.19	10,353	4
2023-03-24	Singleton, Mark Leonard	Officer	SVP & CFO	Direct	Sale	6,044	1.27	$7,675.88	12,581	4
2023-03-15	D'Adamio, Anthony	Officer	SVP & General Counsel	Direct	Sale	3,409	1.39	$4,738.51	45,610	4
2023-03-15	Reali, Kenneth Michael	Director,Officer	Chief Executive Officer	Direct	Sale	9,811	1.39	$13,637.29	30,085	4
2023-03-15	Church, Katrina J	Officer	SVP & Chief Compliance Officer	Direct	Sale	1,332	1.39	$1,851.48	4,624	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

74.56%

Inst. Shares: 50,178,526

Shares Outstanding: 67,296,336

2025-12-31

74.72%

Inst. Shares: 49,779,573

Shares Outstanding: 66,622,631

2025-09-30

73.27%

Inst. Shares: 49,036,890

Shares Outstanding: 66,924,682

2025-06-30

71.80%

Inst. Shares: 47,746,397

Shares Outstanding: 66,500,433

2025-03-31

69.85%

Inst. Shares: 46,110,175

Shares Outstanding: 66,008,683

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	50,178,526	67,296,336	74.56%
2025-12-31	49,779,573	66,622,631	74.72%
2025-09-30	49,036,890	66,924,682	73.27%
2025-06-30	47,746,397	66,500,433	71.80%
2025-03-31	46,110,175	66,008,683	69.85%
2024-12-31	44,761,015	64,547,474	69.35%
2024-09-30	44,268,691	65,258,427	67.84%
2024-06-30	38,304,334	64,056,759	59.80%
2024-03-31	33,721,889	63,380,187	53.21%
2023-12-31	33,039,360	62,647,554	52.74%
2023-09-30	32,670,640	62,824,318	52.00%
2023-06-30	31,873,242	62,551,285	50.96%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Bioventus Inc. (BVS) — SEC Financial Statements & Analysis

Bioventus Inc. (BVS) is a surgical & medical instruments & apparatus company, incorporated in DE. Bioventus Inc. trades on Nasdaq as: BVS. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Bioventus Inc. reported a 1.52% year-over-year revenue growth, a Gross Profit Margin of 68.69% (TTM), a Debt-to-Equity ratio of 2.20x, a Price-to-Sales (P/S) ratio of 1.07x (TTM), a Price-to-Book (P/B) ratio of 3.25 (TTM), at a market cap of $614.42M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 1.52%
Gross Profit Margin TTM: 68.69%
Debt To Equity: 2.20x
P/S TTM: 1.07x
P/B TTM: 3.25
Market Cap: $614.42M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Bioventus Inc. in?

Bioventus Inc. (BVS) operates in the Surgical & Medical Instruments & Apparatus industry.

What is BVS's market cap?

Bioventus Inc. (BVS) has a market capitalization of $614.42M as of 2026-03-31.

What is BVS's P/E ratio?

Bioventus Inc. (BVS)'s trailing twelve month P/E ratio is 20.48x as of 2026-03-31.

What exchange does BVS trade on?

Bioventus Inc. (BVS) trades on the Nasdaq.

Where is Bioventus Inc. incorporated?

Bioventus Inc. is incorporated in DE.

Bioventus Inc. (BVS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.